Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Ohio for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Ohio only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Ohio (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jerome Schartman (NPI 1912113069)

Field	Value
Entity Type	Individual
Organization	Jerome Schartman
Address	3401 Enterprise Pkwy
City	Beachwood
State	OH
ZIP	44122
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	May 15, 2007

Payer Source	Total Paid
Medicare	$2.4M
Medicaid	$0

Key Findings

This provider’s Medicare-centered payer mix is highly concentrated: lifetime Medicare revenue is $2.4M while Medicaid shows none (no Medicaid billing on file), so operations are effectively single‑payer Medicare at scale. The absence of Medicaid claims suggests limited participation in state programs or a practice mix focused on Medicare-eligible patients.

Revenue is overwhelmingly driven by intravitreal biologic therapy: the precomputed top 3 Medicare codes account for 83.9% of total Medicare revenue, and J0178 alone generates $1.8M (74.1% of Medicare revenue) with 2.6K claims and an average paid/claim of $690. This concentration signals that aflibercept injections are the core revenue engine for the practice.

Clinical service mix is consistent with a retina specialty practice that pairs high-volume drug therapy with diagnostic imaging and office exams: large volumes of injection codes (J0178, J2778, J2777, J2781) are complemented by retinal imaging 92134 (2.5K claims, $67.5K revenue) and intermediate/comprehensive exams 92012 (1.1K claims, $67.5K revenue) and 92014 (846 claims, $64.3K revenue). The combination of frequent injections and high retinal imaging volumes indicates an interventional retina clinic managing chronic retinal disease.

Statistical standing is mixed across services: J0178 ranks #278 of 3204 (91th percentile) and is described as a typical, unremarkable national volume despite producing the majority of this provider’s revenue, while 92134 is an extreme outlier (98th percentile) and 92012 also ranks in the 98th percentile as notably above typical national volume. These differences suggest the provider is routine at national levels for the drug administration itself but materially above peers in retinal imaging and certain exam volumes.

There is evidence of modest surgical retina activity alongside the injection-driven practice: surgical codes 67108 (18 claims, $16K revenue, $890 avg paid/claim) and 67042 (15 claims, $12.8K revenue, $855 avg paid/claim) appear at low counts but higher per-claim payments, indicating occasional operative procedures rather than a primary surgical focus. This supports a business model centered on outpatient injections and diagnostics with intermittent surgery.

Use of alternative intravitreal agents is present but uneven: J2778 (ranibizumab) shows 565 claims and $102.3K revenue at the 45th percentile, J2777 (faricimab) reports 2.2K claims and $62.6K revenue but ranks at the 4th percentile, and J2781 (pegcetacoplan) has 225 claims and $27K revenue at the 3th percentile. The mix and percentile spread indicate selective adoption of non‑aflibercept therapies and variability in how these agents are utilized relative to national peers.

Non-procedural evaluation activity supports an active clinic workflow with new and established patient management: 99204 (155 claims, $16.3K revenue) is at the 96th percentile and 99214 (79 claims, $7.2K revenue) is in the 41th percentile, while 92014 and 92012 volumes are notably above typical. High new-patient E/M percentile for 99204 combined with elevated established-patient exam volumes suggests steady referrals and ongoing longitudinal care.

The provider is long‑tenured with an NPI enumeration date of 2007-05-15 (~19 years ago), which likely contributes to stable referral relationships and the concentrated, repeat-treatment revenue profile observed in the Medicare data. Tenure aligns with the sustained reliance on high-volume injection services and frequent retinal imaging.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,610	$690	$1.8M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,560	$90	$134.5K
J2778	Injection, ranibizumab, 0.1 mg	570	$180	$102.3K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	1,110	$60	$67.5K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,500	$30	$67.5K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	850	$80	$64.3K
J2777	Injection, faricimab‑svoa, 0.1 mg	2,160	$30	$62.6K
J3590	Unclassified biologics	370	$100	$36.6K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	230	$120	$27K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	160	$110	$16.3K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Ohio Distribution

Jerome Schartman — 4 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Ohio

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	8	100	840	$680	$729K
J2777	66	70	9,480	$30	$353.3K
J2781	17	20	1,040	$120	$152.4K
J2778	2	20	370	$180	$73.1K
67028	20	150	470	$90	$64K
J3590	35	100	200	$100	$30K
67042	38	50	20	$960	$29.7K
67108	14	30	20	$1,020	$26.5K
92014	26	1,390	100	$70	$12.9K
99214	11,219	20,010	100	$70	$11.7K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jerome Schartman, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Retina Associates Of Cleveland, Inc.	OH	Retina Specialist (Ophthalmology) Physician	$0	$11.2M
Scott Pendergast	OH	Retina Specialist (Ophthalmology) Physician	$6M	$0
David Miller	OH	Retina Specialist (Ophthalmology) Physician	$4.8M	$0
Llewelyn Rao	OH	Retina Specialist (Ophthalmology) Physician	$3.7M	$0
Joseph Coney	OH	Retina Specialist (Ophthalmology) Physician	$3.2M	$140
Arnold Nothnagel	OH	Retina Specialist (Ophthalmology) Physician	$2.9M	$0
Shawn Lewis	OH	Retina Specialist (Ophthalmology) Physician	$2.8M	$0
Thomas Hull	OH	Retina Specialist (Ophthalmology) Physician	$2.6M	$0
Hang Pham	OH	Ophthalmology Physician	$2.6M	$0
Michael Novak	OH	Retina Specialist (Ophthalmology) Physician	$2.5M	$0

Nearby Providers

Other providers in the same ZIP code as Jerome Schartman, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Primary Care Practices Inc	OH	Internal Medicine Physician	$0	$78.7M
Pearl's Hope, LLC	OH	Home Health Agency	$0	$47.8M
Health Care Bridge, Inc	OH	Home Health Agency	$0	$32.3M
Cleveland Clinic Health System - East Region	OH	General Acute Care Hospital	$0	$31.5M
Altimate Care LLC	OH	Home Health Agency	$0	$24M
Signature Health, Inc	OH	Federally Qualified Health Center (FQHC)	$0	$23M
University Hospitals Ahuja Medical Center, Inc	OH	General Acute Care Hospital	$0	$21.1M
Shaker Clinic, LLC	OH	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$15.5M
Psychological & Behavioral Consultants, LLC	OH	Psychiatry Physician	$0	$14.9M
Northeast Home Health Services	OH	Home Health Agency	$0	$11.9M

Jerome Schartman — Billing Profile & Reimbursement Data

Sign up for Jerome Schartman — Billing Profile & Reimbursement Data policy alerts

Jerome Schartman — Billing Profile & Reimbursement Data

Sign up for Jerome Schartman — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References